Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1993 2
1994 3
1996 1
1997 3
1998 2
1999 4
2000 3
2001 3
2002 5
2004 1
2005 2
2006 1
2007 1
2008 5
2009 6
2010 5
2011 5
2012 3
2013 7
2014 6
2015 5
2016 5
2017 3
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
Wilhelmus MM, de Jager M, Bakker EN, Drukarch B. Wilhelmus MM, et al. J Alzheimers Dis. 2014;42 Suppl 3:S289-303. doi: 10.3233/JAD-132492. J Alzheimers Dis. 2014. PMID: 24685636 Review.
Protein misfolding and the formation of stable insoluble protein complexes by self-interacting proteins, in particular amyloid-beta and tau protein, play a central role in the pathogenesis of Alzheimer's disease (AD). Unfortunately, the underlying mechanisms …
Protein misfolding and the formation of stable insoluble protein complexes by self-interacting proteins, in particular amyloid-beta and tau …
[Transglutaminase and neurodegenerative diseases].
Liu Z, Zeng J, Zeng S, Tang B, Wang J. Liu Z, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):562-6. doi: 10.3760/cma.j.issn.1003-9406.2015.04.025. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. PMID: 26252108 Review. Chinese.
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of multiple diseases. Notably, neurodegenerative diseases such as Huntington's disease, spinocerebellar ataxia, Alzheimer
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of …
Transglutaminase 2 and neuroinflammation.
Ientile R, Currò M, Caccamo D. Ientile R, et al. Amino Acids. 2015 Jan;47(1):19-26. doi: 10.1007/s00726-014-1864-2. Epub 2014 Nov 15. Amino Acids. 2015. PMID: 25398223 Review.
Several findings emphasize the possible role of the TG2/NF-kappaB activation pathway in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. ...
Several findings emphasize the possible role of the TG2/NF-kappaB activation pathway in neurodegenerative diseases, including Alzheimer
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Martin A, Giuliano A, Collaro D, De Vivo G, Sedia C, Serretiello E, Gentile V. Martin A, et al. Amino Acids. 2013 Jan;44(1):111-8. doi: 10.1007/s00726-011-1081-1. Epub 2011 Sep 22. Amino Acids. 2013. PMID: 21938398 Review.
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, supranuclear palsy …
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative d …
Transglutaminase 2 in neurodegenerative disorders.
Ruan Q, Johnson GV. Ruan Q, et al. Front Biosci. 2007 Jan 1;12:891-904. doi: 10.2741/2111. Front Biosci. 2007. PMID: 17127346 Review.
Most importantly, numerous studies have presented data demonstrating that dysregulation of TG2 may contribute to the pathogenesis of many neurodegenerative disorders, including Huntington's disease, Alzheimer's disease, Parkinson's dis
Most importantly, numerous studies have presented data demonstrating that dysregulation of TG2 may contribute to the pathogenesis of many ne …
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Iannaccone M, Titta F, Serretiello E, De Vivo G, Martin A, Gentile V. Iannaccone M, et al. Recent Pat CNS Drug Discov. 2013 Dec;8(3):235-42. doi: 10.2174/1574889808666131128105630. Recent Pat CNS Drug Discov. 2013. PMID: 24286449 Review.
Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological processes. For example, neurodegenerative diseases, such as Alzheimer's Disease, Parkinson's Disease, supranuc …
Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological proce …
Transglutaminase and diseases of the central nervous system.
Hoffner G, Djian P. Hoffner G, et al. Front Biosci. 2005 Sep 1;10:3078-92. doi: 10.2741/1764. Front Biosci. 2005. PMID: 15970562 Review.
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insoluble protein aggregates and neuronal death. ...
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insol
Critical role of transglutaminase and other stress proteins during neurodegenerative processes.
Caccamo D, Currò M, Condello S, Ferlazzo N, Ientile R. Caccamo D, et al. Amino Acids. 2010 Feb;38(2):653-8. doi: 10.1007/s00726-009-0428-3. Epub 2009 Dec 5. Amino Acids. 2010. PMID: 19960212 Review.
Proteolytic stress, resulting from the intracellular accumulation of misfolded or aggregated proteins, which exceed the capacity of the ubiquitin-proteasome system to degrade them, plays a relevant role in neurodegenerative disorders, such as Alzheimer's disease
Proteolytic stress, resulting from the intracellular accumulation of misfolded or aggregated proteins, which exceed the capacity of the ubiq …
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Iannaccone M, Serretiello E, De Vivo G, Martin A, Stefanile A, Titta F, Gentile V. Iannaccone M, et al. Recent Pat CNS Drug Discov. 2013 Aug;8(2):161-8. doi: 10.2174/15748898113089990001. Recent Pat CNS Drug Discov. 2013. PMID: 23688272 Review.
Recently, "tissue" transglutaminase (transglutaminase 2), a member of the transglutaminase family of enzymes, has been shown to be involved in the molecular mechanisms responsible for some human pathologies, including celiac disease, a very widespread human pathology. Tran …
Recently, "tissue" transglutaminase (transglutaminase 2), a member of the transglutaminase family of enzymes, has been shown to be involved …
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
Wilhelmus MM, van Dam AM, Drukarch B. Wilhelmus MM, et al. Eur J Pharmacol. 2008 May 13;585(2-3):464-72. doi: 10.1016/j.ejphar.2008.01.059. Epub 2008 Mar 18. Eur J Pharmacol. 2008. PMID: 18417122 Review.
Alzheimer's disease, Parkinson's disease and Huntington's disease are neurodegenerative diseases, characterized by the accumulation and deposition of neurotoxic protein aggregates. ...So far, increased levels and activity of tissue
Alzheimer's disease, Parkinson's disease and Huntington's disease are neurodegenerative dis
69 results